Health Economist

Institute of Cancer Research

  • Chelsea, South West London
  • £50,825-61,525 per year
  • Contract
  • Full-time
  • 15 days ago
Salary: Commencement on the salary range is subject to comparable skills and experience.Reporting to: Professor Axel BehrensAccountable to: Dr Patrick KierkegaardDuration of Contract: Fixed Term for 2 years (with possibility of extension)Hours per week: 35 hours per week (Full Time)Location: ChelseaClosing Date: 16th September 2025This role is eligible for ICR Sponsorship. Support will be provided for costs associated with Visa application. If you are considering relocating to the UK, further information can be found .Job DetailsUnder the guidance of Cancer Technology Catalyst team lead we are seeking to recruit a Health Economist to pioneer evaluations at the CRUK Convergence Science Centre. Based in South Kensington, London, with travel to partner sites (The Royal Marsden NHS Foundation Trust, ICR Sutton, Imperial College Healthcare NHS Trust). The successful candidate will lead early-stage health economic modelling and health technology assessment (HTA) for cutting-edge oncology innovations, including precision drugs, diagnostics, treatments, clinical guidelines, and digital health technologies (DHTs).Department/Directorate InformationThe (CSC) is a partnership between Imperial College London and The Institute of Cancer Research (ICR) with funding from Cancer Research UK. Convergence research is driven by a societal need and utilises a deep integration across disciplines. Professor Axel Behrens is the Scientific Director of the CRUK Convergence Science Centre.This position of Health Economist is integrated within our Cancer Technology Catalyst team (CTC). The CTC is an initiative designed to expedite the journey of promising cancer technologies from concept to clinical impact. Led by a diverse team of experts, the CTC is committed to unlocking the full potential of innovative solutions and addressing the challenges inherent in bringing them to patients. By harnessing a collaborative Team Science approach, the CTC works closely with Principal Investigators and their teams to develop comprehensive evidence packages that not only inform robust value propositions for cancer technologies, but also strategically position them for successful clinical integration.About youPlease see the attached for essential skills and qualifications for this role, and further information.What we offer
  • A dynamic and supportive research environment
  • Access to state-of-the-art facilities and professional development opportunities
  • Collaboration with leading researchers in the field
  • Competitive salary and pension
We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Patrick Kierkegaard via p.kierkegaard@imperial.ac.uk.£50,825 to £61,525 per annum

Jobs.ac.uk